ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
IN8bio Inc

IN8bio Inc (INAB)

0.8778
0.0377
(4.49%)
Closed July 13 4:00PM
0.8531
-0.0247
(-2.81%)
After Hours: 7:47PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.8531
Bid
0.8531
Ask
0.94
Volume
72,948
0.844243 Day's Range 0.905
0.65 52 Week Range 2.48
Market Cap
Previous Close
0.8401
Open
0.905
Last Trade
5
@
0.8795
Last Trade Time
Financial Volume
$ 63,349
VWAP
0.868419
Average Volume (3m)
408,956
Shares Outstanding
44,123,949
Dividend Yield
-
PE Ratio
-1.29
Earnings Per Share (EPS)
-0.68
Revenue
-
Net Profit
-30.01M

About IN8bio Inc

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was $0.84. Over the last year, IN8bio shares have traded in a share price range of $ 0.65 to $ 2.48.

IN8bio currently has 44,123,949 shares outstanding. The market capitalization of IN8bio is $37.07 million. IN8bio has a price to earnings ratio (PE ratio) of -1.29.

INAB Latest News

IN8bio to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced...

IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100

100% of treated leukemia patients (n=10/10) achieved durable complete remission (CR) at 1-year, including high-risk and relapsed acute myeloid leukemia (AML) patients who had previously failed...

IN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Society of Clinical Oncology Annual Meeting

92% of evaluable patients treated with INB-200 for glioblastoma exceeded a median progression-free survival (PFS) of seven months achieved with the standard-of-care regimen (Stupp regimen...

IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024

NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced multiple...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.05466.837820914210.79850.9050.77941371210.83431684CS
4-0.6469-43.12666666671.51.50.76056715870.99916462CS
12-0.1669-16.3627450981.021.740.76054089561.16843004CS
26-0.7469-46.681251.61.740.76053612331.15695492CS
52-0.8669-50.40116279071.722.480.653647121.3208259CS
156-9.1469-91.4691010.3190.655858712.46521952CS
260-9.1469-91.4691010.3190.655858712.46521952CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.69M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

INAB Discussion

View Posts
glenn1919 glenn1919 1 month ago
INAB....................................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 1 month ago
INAB.................................https://stockcharts.com/h-sc/ui?s=INAB
&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Tyrus603 Tyrus603 3 months ago
Talk about a delayed effect. But once more investors fully absorb the news... How big is the leukemia prescribed drug treatment market? Sky high run still possible.
πŸ‘οΈ0
Laster Laster 3 months ago
Sold my shares this morning that I bought last night for small loss.
Volume not great. No PM movement (yet).
Who knows. It may surprise and take off at 9:30 open.
If it does, then congrats to y’all.
πŸ‘οΈ0
Invest-in-America Invest-in-America 3 months ago
INAB: Their Post-M news relates only PRE-Human findings, etc., at this point --- but, you simply publish a MAYBE-WE-GOT-A-POTENTIAL-CANCER-CURE type of PR and well, you know, a PRICE Moon landing tomorrow morning maybe??? (Holding circa 35% up in the Post-M, at this writing.)

BOTTOM LINE??? GO-GO-GO-INAB!!!!
πŸ‘οΈ0
glenn1919 glenn1919 4 months ago
INAB.........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
INAB under $2
πŸ‘οΈ0
murocman murocman 7 months ago
Surprised how much this has tanked in light of stellar data?

Murocman
πŸ‘οΈ0
murocman murocman 7 months ago
Outstanding data and financing in place to boot!

Should move up!

Murocman
πŸ‘οΈ0
Awl416 Awl416 7 months ago
IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
INAB under $2
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
INAB new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
INAB new 52 week low
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
https://stockcharts.com/h-sc/ui?s=inab&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
like this
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
like this
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
looks good
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
dip
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
dip
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
nice
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
strong chart
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
reaDY
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
reaDY
πŸ‘οΈ0
Mr Wick Mr Wick 1 year ago
New INB 200 phase 1 data evaluating INB 200 patients will be available on Thursday 25 May. Also being presented at ASCO annual meeting on 02 June.
Fingers crossed.
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
nice
πŸ‘οΈ0
MrMocha MrMocha 1 year ago
I agree, INAB is going to do great things. A majority of their trials so far show great promise! I’m excited to see what their future holds..I can definitely see them being acquired in the not so distant future. Great find Mr Wick!
👍️ 1
Mr Wick Mr Wick 1 year ago
New to ihub. Found in8bio a few weeks ago after the huge run recently. After researching I told a friend that " in8bio might be the best sleeper stock I have ever seen".
Looking forward to a buyout.
👍️ 1
The Night Stalker The Night Stalker 1 year ago
right on
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
strong as hell
πŸ‘οΈ0
Trons Trons 1 year ago
Headed to $20 on cancer developments
πŸ‘οΈ0
Jess070283 Jess070283 1 year ago
Uh oh Shorts I’m trouble….
πŸ‘οΈ0
trendzone trendzone 1 year ago
Real DUMBASS move by the company this mornings news of offerings, but with the other big news out this week, it's probably a screaming buy on the reversal selloff, and sellers are acting like the fools that they are.
πŸ‘οΈ0
Jess070283 Jess070283 1 year ago
Loading this dip for the rip…
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
INAB: It is CUTE!! (Hey, Boss, PBLA & INAB lookin' interesting; so too SAI, of course.)
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
Update: IN8bio's INB-400, INB-410 Secure US FDA's Orphan Drug Designation -- Shares Surge Premarket
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target
πŸ‘οΈ0
subslover subslover 1 year ago
Love your scanner! :)
πŸ‘οΈ0
2020Benzo 2020Benzo 1 year ago
Did they just post same Orphan Drug news twice in a row it’s sane PR !
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
sub $2
πŸ‘οΈ0
surf1944 surf1944 1 year ago
https://stockcharts.com/h-sc/ui?s=inab&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/inab/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/inab/opinion

Back down to $1
πŸ‘οΈ0
ringo1 ringo1 1 year ago
Time to take some profits
πŸ‘οΈ0
Hercules1 Hercules1 1 year ago
It hit $3.95.

$4 break is coming.


$5 quite possible today.
πŸ‘οΈ0
Hercules1 Hercules1 1 year ago
Total beast.

Next stop $4.

And then $5.
πŸ‘οΈ0
Awl416 Awl416 1 year ago
Impressive day
πŸ‘οΈ0
Jess070283 Jess070283 1 year ago
What a beast!
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
INAB: Maybe I've gone BONKERS, but this little freak show could hit TEN-BUCKS-A-SHARE today, Peeps!!!! (At least that's what my 'SCANNER' just told me!! See below!!)

πŸ‘οΈ0
Hercules1 Hercules1 1 year ago
This skyrockets to $5 today.

This is just getting started.


πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
INAB: Howdy, Herc!!! Guess us TWO chaps will have to PARTY all by ourselves over here today on this silly little iHub Board!! Heck, I guess nobody else but US two could figure-out what INAB's cute PR was all about!! (HA-HAAAAAAA!!!)

Lastly, check-out what my 'BROKER' (see below) had to say to me about this INAB stock, very early this morning:
πŸ‘οΈ0
Hercules1 Hercules1 1 year ago
Price target:

$14


News is absolutely huge.

πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
INAB: This is iHub's legendary "INVEST-IN-AMERICA", with a very succinct DIRECT ORDER for INAB's entire High Seas Fleet --- to wit, OPEN-FIRE-NOW!!!

πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
INAB: Might get a little run-up later today, when all of the insider dumping subsides. I mean heck, pretty decent PR.
https://seekingalpha.com/news/3959103-in8bio-stock-rises-cancer-drug-inb-100-shows-promise-phase-1-trial

πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock